Company news: Zelira Therapeutics; Epsilon Healthcare; Creso Pharma by Martin Lane and Steve Jones May 23, 2023April 30, 2024 ASX-listed Zelira Therapeutics has raised another US$3.25 million (A$4.89m) towards the cost of its US clinical […]
Epsilon secures A$1.65m in capital raise with backing from former CEO by Steve Jones September 2, 2022April 29, 2024
Epsilon future uncertain as half-year losses climb by 94% by Martin Lane September 1, 2022April 29, 2024
Company news: Rua Bioscience; Emyria; InhaleRx; Cannasouth; Roots: Creso Pharma; Epsilon by cannabiz team December 2, 2021April 29, 2024
Epsilon Healthcare and The Valens Company enter into exclusive partnership by Hannah Adler September 9, 2021April 26, 2024
Company news: Elixinol Global; Bod Australia; MGC Pharma; Cronos Australia; Epsilon Healthcare by Martin Lane April 23, 2021April 26, 2024
